LAVA Medtech Acquisition Corp. (the “Company”) is a blank check company incorporated in Delaware on March 31, 2021. The Company was formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses (the “Business Combination”).
Company profile
Ticker
LVACW, LVACW
Exchange
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
SEC CIK
IRS number
862973712
LVACW stock data
Latest filings (excl ownership)
15-12G
Securities registration termination
15 May 23
25-NSE
Exchange delisting
12 May 23
8-K
Other Events
10 May 23
8-K
LAVA Medtech Acquisition Corp. Announces Liquidation
1 May 23
8-K
Other Events
18 Apr 23
DEF 14A
Definitive proxy
10 Apr 23
10-K
2022 FY
Annual report
29 Mar 23
PRE 14A
Preliminary proxy
27 Mar 23
10-Q
2022 Q3
Quarterly report
14 Nov 22
10-Q
2022 Q2
Quarterly report
15 Aug 22
Latest ownership filings
SC 13G/A
Saba Capital Management, L.P.
9 Feb 24
SC 13G/A
Castle Creek Arbitrage, LLC
10 Jan 24
SC 13G
Shaolin Capital Management LLC
14 Feb 23
SC 13G
PERISCOPE CAPITAL INC.
13 Feb 23
SC 13G/A
Castle Creek Arbitrage, LLC
13 Feb 23
SC 13G
Saba Capital Management, L.P.
13 May 22
SC 13G
LAVA Medtech Sponsor LP
14 Feb 22
SC 13G/A
Beryl Capital Management LLC
11 Feb 22
SC 13G
Castle Creek Arbitrage, LLC
11 Feb 22
SC 13G
Polar Asset Management Partners Inc.
9 Feb 22
Financial summary
Quarter (USD) | Dec 22 | Sep 22 | Jun 22 | Mar 22 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 22 | Dec 21 | |
---|---|---|---|
Revenue | |||
Cost of revenue | |||
Operating income | |||
Operating margin | |||
Net income | |||
Net profit margin | |||
Cash on hand | |||
Change in cash | |||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 1.16 mm | 1.16 mm | 1.16 mm | 1.16 mm | 1.16 mm | 1.16 mm |
Cash burn (monthly) | (no burn) | 31.84 k | (no burn) | (no burn) | 245.25 k | 255.40 k |
Cash used (since last report) | n/a | 674.34 k | n/a | n/a | 5.19 mm | 5.41 mm |
Cash remaining | n/a | 484.81 k | n/a | n/a | -4.04 mm | -4.25 mm |
Runway (months of cash) | n/a | 15.2 | n/a | n/a | -16.5 | -16.6 |
Institutional ownership, Q3 2023
0.0% owned by funds/institutions
13F holders | Current |
---|---|
Total holders | 1 |
Opened positions | 0 |
Closed positions | 0 |
Increased positions | 0 |
Reduced positions | 0 |
13F shares | Current |
---|---|
Total value | 0.00 |
Total shares | 2.88 mm |
Total puts | 0.00 |
Total calls | 0.00 |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|---|---|
LAVA Medtech Sponsor | 2.88 mm | $0.00 |